AbbVie
ABBV
#25
Rank
$519.48 B
Marketcap
$293.89
Share price
0.20%
Change (1 day)
34.37%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): $12.81 Billion USD

According to AbbVie's latest financial reports the company's current earnings are $66.01 Billion USD. In 2025 the company made an earning of $6.59 Billion USD, an increase over its 2024 earnings that were of $3.71 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $12.81 B94.24%
2025 $6.59 B77.53%
2024 $3.71 B-40.54%
2023 $6.25 B-53.62%
2022 $13.47 B3.76%
2021 $12.98 B282.25%
2020 $3.39 B-59.67%
2019 $8.42 B62.13%
2018 $5.19 B-32.74%
2017 $7.72 B-1.99%
2016 $7.88 B18.65%
2015 $6.64 B180.5%
2014 $2.36 B-55.57%
2013 $5.33 B-6.86%
2012 $5.72 B56.05%
2011 $3.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$6.96 B-45.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$34.76 B 171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.05 B-13.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$0.44 B-96.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-$2.54 Billion-119.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.33 B-11.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$15.08 B 17.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$7.15 B-44.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.86 B-93.27%๐Ÿ‡บ๐Ÿ‡ธ USA